Antibody-drug Conjugate/ADC Related

Antibody-Drug Conjugates (ADCs) are a class of complex anti-tumor drugs composed of monoclonal antibodies targeting specific antigens, linkers, and cytotoxic small-molecule payloads. They combine the high targeting specificity of antibody drugs with the potent killing ability of traditional small-molecule chemotherapeutic drugs, thereby achieving more precise and efficient tumor treatment. They mainly consist of antibodies, linkers, and payloads. TargetMol can provide all components and the conjugated molecules to meet various research needs.